My WebLink
|
Help
|
About
|
Sign Out
Home
Browse
Search
2024_OpioidSettlemtAgrmt_JanssenJJ
>
Meetings
>
2024
>
04. April
>
2024-04-16 10:00 AM - Commissioners' Agenda
>
2024_OpioidSettlemtAgrmt_JanssenJJ
Metadata
Thumbnails
Annotations
Entry Properties
Last modified
4/11/2024 1:10:33 PM
Creation date
4/11/2024 1:08:48 PM
Metadata
Fields
Template:
Meeting
Date
4/16/2024
Meeting title
Commissioners' Agenda
Location
Commissioners' Auditorium
Address
205 West 5th Room 109 - Ellensburg
Meeting type
Regular
Meeting document type
Supporting documentation
Supplemental fields
Item
Request to Approve a Resolution Accepting the Johnson & Johnson (Janssen) Washington State State-Wide Opioid Settlement Agreement
Order
7
Placement
Consent Agenda
Row ID
116716
Type
Agreement
There are no annotations on this page.
Document management portal powered by Laserfiche WebLink 9 © 1998-2015
Laserfiche.
All rights reserved.
/
127
PDF
Print
Pages to print
Enter page numbers and/or page ranges separated by commas. For example, 1,3,5-12.
After downloading, print the document using a PDF reader (e.g. Adobe Reader).
View images
View plain text
<br />J-13 <br /> <br /> <br />10. Expanding access to testing and treatment for infectious diseases such as HIV and <br />Hepatitis C resulting from intravenous opioid use. <br />11. Supporting mobile units that offer or provide referrals to harm reduction services, <br />treatment, recovery supports, health care, or other appropriate services to persons that <br />use opioids or persons with OUD and any co-occurring SUD/MH conditions. <br />12. Providing training in harm reduction strategies to health care providers, students, peer <br />recovery coaches, recovery outreach specialists, or other professionals that provide <br />care to persons who use opioids or persons with OUD and any co-occurring SUD/MH <br />conditions. <br />13. Supporting screening for fentanyl in routine clinical toxicology testing. <br />PART THREE: OTHER STRATEGIES <br /> <br />I. FIRST RESPONDERS <br />In addition to items in section C, D and H relating to first responders, support the <br />following: <br />1. Education of law enforcement or other first responders regarding appropriate <br />practices and precautions when dealing with fentanyl or other drugs. <br />2. Provision of wellness and support services for first responders and others who <br />experience secondary trauma associated with opioid-related emergency events. <br />J. LEADERSHIP, PLANNING AND COORDINATION <br />Support efforts to provide leadership, planning, coordination, facilitations, training and <br />technical assistance to abate the opioid epidemic through activities, programs, or <br />strategies that may include, but are not limited to, the following: <br />1. Statewide, regional, local or community regional planning to identify root causes of <br />addiction and overdose, goals for reducing harms related to the opioid epidemic, and <br />areas and populations with the greatest needs for treatment intervention services, and <br />to support training and technical assistance and other strategies to abate the opioid <br />epidemic described in this opioid abatement strategy list. <br />2. A dashboard to (a) share reports, recommendations, or plans to spend opioid <br />settlement funds; (b) to show how opioid settlement funds have been spent; (c) to <br />report program or strategy outcomes; or (d) to track, share or visualize key opioid- or <br />health-related indicators and supports as identified through collaborative statewide, <br />regional, local or community processes. <br />3. Invest in infrastructure or staffing at government or not-for-profit agencies to support <br />collaborative, cross-system coordination with the purpose of preventing
The URL can be used to link to this page
Your browser does not support the video tag.